Documents

Formal response by the GAVI Senior Management team for the GAVI Alliance Board to the recommendations of the 'Evaluation of the first five years of GAVI Immunisation Services Support funding'.

As GAVI enters its second phase, it is interested in evaluating whether ISS funding continues to further GAVI's objectives, and how best to maximise any positive impact. The Request for Proposal (RFP) issued by GAVI indicated three specific objectives: to assess the experience of the ISS scheme in Phase 1 (2000-2005); to assess the application [implementation] of ISS funding at country level and its relation to overall immunisation financing; to identify the relationship between the allocation of ISS funding and immunisation coverage rates (DTP3)

The Independent Expert Committee was convened to assess which of the six vaccines included in the Tremonti report would be most suitable for the pilot AMC.

In May 2007, the AMC Donor Committee constituted an independent Economic Expert Group (EEG) to advise on the initial AMC design. This document is the donors' response to the EEG report.

The address Pope Benedict XVI gave to the representatives of the Advance Market Commitment in Rome, Italy on 9 February 2007.

Statement from the Bill and Melinda Gates foundation announcing support for the pneumococcal AMC.

Remarks of Her Majesty Queen Rania Al-Abdullah on the announcement of Advanced Market Commitments of $1.5 billion in Rome, Italy on 9 February 2007.

The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) welcomes the public commitment made by the governments of Canada, Italy, Norway and the United Kingdom to fund the pilot Advance Market Commitment (AMC) to stimulate the development of new pneumococcal vaccines for the poorest countries.

Streptococcus pneumoniae are bacteria that are frequently found in the upper respiratory tract of healthy children and adults. These bacteria, however, can also cause a range of infections – from relatively mild ear infections to fatal pneumonia, meningitis, and sepsis. Serious pneumococcal infections can occur throughout life, but children under two years old and the elderly are at highest risk. 

Stories of three young children in Africa and Asia and their fight against pneumococcal disease.

The Terms of Reference of the study are: to take stock of the way the environment for new vaccine development and introduction has evolved over the past four years; to assess the progress made and highlight the lessons learnt through the innovative ADIPs approach, the Hib initiative and other new vaccine introduction related GAVI supported activities; and, to make recommendations to the GAVI Board on the structure and finance [of] its continued support in this priority area in the coming years.